How can we improve rural mental health?
John Kraus, MD, PhD
Advertisement
Articles by John Kraus, MD, PhD
Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.
New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
2
Candy and Other Food Treats or Tricks
3
The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth
4
“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples
5
